These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 142579)

  • 21. Combination chemotherapy with cyclophosphamide plus 5-fluorouracil for the treatment of unresectable pancreatic adenocarcinoma.
    Chlebowski R; Gota C; Glass A; Weiner J; Bateman JR
    Cancer Treat Rep; 1979; 63(11-12):2119-21. PubMed ID: 526947
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative therapeutic trial of radiation with or without chemotherapy in pancreatic carcinoma. Gastrointestinal Tumor Study Group.
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1643-7. PubMed ID: 395141
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequential and combination chemotherapy of advanced gastric cancer.
    Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
    Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
    Tucker WG; Talley RW; Lane M; Bonnet JD
    Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of advanced colon cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil: prognostic aspects of the differential white blood cell count.
    Chlebowski RT; Silverberg I; Pajak T; Weiner J; Kardinal C; Bateman JR
    Cancer; 1980 May; 45(9):2240-4. PubMed ID: 6991095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
    Cullinan S; Moertel CG; Wieand HS; Schutt AJ; Krook JE; Foley JF; Norris BD; Kardinal CG; Tschetter LK; Barlow JF
    Cancer; 1990 May; 65(10):2207-12. PubMed ID: 2189551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; Hanley JA
    Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity.
    Ihde DC; Cohen MH; Bunn PA; Bernath AM; Broder LE; Minna JD
    Cancer Treat Rep; 1978 Jan; 62(1):155-7. PubMed ID: 75065
    [No Abstract]   [Full Text] [Related]  

  • 32. Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.
    Kraybill WG; Anderson DD; Lindell TD; Fletcher WS
    Am Surg; 1976 Jul; 42(7):467-70. PubMed ID: 180857
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer.
    Yagoda A; Watson RC; Kemeny N; Barzell WE; Grabstald H; Whitmore WF
    Cancer; 1978 Jun; 41(6):2121-30. PubMed ID: 657084
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
    Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
    Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.
    Klaassen DJ; MacIntyre JM; Catton GE; Engstrom PF; Moertel CG
    J Clin Oncol; 1985 Mar; 3(3):373-8. PubMed ID: 3973648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
    Eagan RT; Utz DC; Myers RP; Furlow WL
    Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas: a Southwest Oncology Group Study.
    McCracken JD; Ray P; Heilbrun LK; Vaitkevicius VK; Saiki JH; Rivkin SE; Rossof AH; Moore TN
    Cancer; 1980 Oct; 46(7):1518-22. PubMed ID: 6998556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230.
    Awrich A; Fletcher WS; Klotz JH; Minton JP; Hill GJ; Aust JB; Grage TB; Multhauf PM
    J Surg Oncol; 1979; 12(3):267-73. PubMed ID: 228123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.
    Broder LE; Carter SK
    Ann Intern Med; 1973 Jul; 79(1):108-18. PubMed ID: 4352784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.